{"BACKGROUND:": [0], "Risk": [1], "stratification": [2, 36, 266], "and": [3, 23, 68, 80, 149, 179, 220, 231, 258, 271, 308, 323, 341, 364], "therapeutic": [4], "decision-making": [5], "for": [6, 62, 73, 112, 193, 249, 276, 320, 344, 354], "myelodysplastic": [7], "syndromes": [8], "(MDS)": [9], "are": [10, 29], "based": [11], "on": [12, 347], "the": [13, 34, 89, 100, 185, 208, 210, 239, 261, 264, 284, 287, 292, 297, 303, 317, 328, 332, 348, 351, 355, 359, 368], "International": [14], "Prognostic": [15], "Scoring": [16], "System\u2013Revised": [17], "(IPSS-R),": [18], "which": [19], "considers": [20], "hematologic": [21, 175, 257], "parameters": [22], "cytogenetic": [24, 177, 259], "abnormalities.": [25], "Somatic": [26], "gene": [27], "mutations": [28, 63, 160, 181], "not": [30], "yet": [31], "used": [32], "in": [33, 64, 118, 137, 188, 229], "risk": [35, 191, 201, 265], "of": [37, 91, 99, 122, 139, 155, 172, 182, 223, 238, 267, 299, 302, 306, 336, 357, 362], "patients": [38, 57, 125, 140, 268], "with": [39, 58, 75, 126, 141, 163, 203, 207, 256, 269], "MDS.": [40, 127, 142, 233], "METHODS:": [41], "To": [42, 234], "develop": [43], "a": [44, 106, 189, 273], "clinical-molecular": [45], "prognostic": [46, 94, 204, 213], "model": [47, 110], "(IPSS-Molecular": [48], "[IPSS-M]),": [49], "pretreatment": [50], "diagnostic": [51], "or": [52], "peridiagnostic": [53], "samples": [54], "from": [55], "2957": [56], "MDS": [59, 270, 285, 369], "were": [60, 71, 103, 161], "profiled": [61], "152": [65], "genes.": [66], "Clinical": [67], "molecular": [69], "variables": [70, 102], "evaluated": [72], "associations": [74], "leukemia-free": [76], "survival,": [77], "leukemic": [78], "transformation,": [79], "overall": [81], "survival.": [82], "Feature": [83], "selection": [84], "was": [85, 116, 168, 227], "applied": [86], "to": [87], "determine": [88], "set": [90], "independent": [92], "IPSS-M": [93, 115, 186, 200, 211, 226, 262], "variables.": [95], "The": [96, 114, 225], "relative": [97], "weights": [98], "selected": [101], "estimated": [104], "using": [105], "robust": [107], "Cox": [108], "multivariable": [109], "adjusted": [111], "confounders.": [113], "validated": [117], "an": [119, 243], "external": [120], "cohort": [121], "754": [123], "Japanese": [124], "RESULTS:": [128], "We": [129, 196], "mapped": [130], "at": [131], "least": [132], "one": [133], "oncogenic": [134], "genomic": [135, 254], "alteration": [136], "94%": [138], "Multivariable": [143], "analysis": [144], "identified": [145], "TP53multihit,": [146], "FLT3": [147], "mutations,": [148], "MLLPTD": [150], "as": [151], "top": [152], "genetic": [153], "predictors": [154], "adverse": [156], "outcomes.": [157], "Conversely,": [158], "SF3B1": [159], "associated": [162], "favorable": [164], "outcomes,": [165], "but": [166], "this": [167], "modulated": [169], "by": [170, 280], "patterns": [171], "comutation.": [173], "Using": [174], "parameters,": [176, 260], "abnormalities,": [178], "somatic": [180], "31": [183], "genes,": [184], "resulted": [187], "unique": [190], "score": [192], "individual": [194], "patients.": [195, 224], "further": [197], "derived": [198], "six": [199], "categories": [202], "differences.": [205], "Compared": [206], "IPSS-R,": [209], "improved": [212], "discrimination": [214], "across": [215], "all": [216], "clinical": [217, 236, 277], "end": [218], "points": [219], "restratified": [221], "46%": [222], "applicable": [228], "primary": [230], "secondary/therapy-related": [232], "simplify": [235], "use": [237], "IPSS-M,": [240], "we": [241], "developed": [242], "open-access": [244], "Web": [245], "calculator": [246], "that": [247], "accounts": [248], "missing": [250], "values.": [251], "CONCLUSIONS:": [252], "Combining": [253], "profiling": [255], "improves": [263], "represents": [272], "valuable": [274], "tool": [275], "decision-making.": [278], "(Funded": [279], "Celgene": [281, 365], "Corporation": [282, 366], "through": [283, 367], "Foundation,": [286, 296], "Josie": [288], "Robertson": [289], "Investigators": [290], "Program,": [291], "Edward": [293], "P.": [294], "Evans": [295], "Projects": [298], "National": [300], "Relevance": [301], "Italian": [304], "Ministry": [305, 335], "University": [307], "Research,": [309], "Associazione": [310], "Italiana": [311], "per": [312], "la": [313], "Ricerca": [314], "sul": [315], "Cancro,": [316], "Japan": [318, 352], "Agency": [319], "Medical": [321], "Research": [322, 326, 346], "Development,": [324], "Cancer": [325], "UK,": [327], "Austrian": [329], "Science": [330, 340], "Fund,": [331], "MEXT": [333], "[Japanese": [334], "Education,": [337], "Culture,": [338], "Sports,": [339], "Technology]": [342], "Program": [343], "Promoting": [345], "Supercomputer": [349], "Fugaku,": [350], "Society": [353], "Promotion": [356], "Science,": [358], "Taiwan": [360], "Department": [361], "Health,": [363], "Foundation.)": [370]}